How Early Can Checkpoint Inhibitors Induce a Complete Metabolic Response in Chemorefractory Hodgkin Lymphoma?

From the ∗Department of Haematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, School of Medicine

†Department of Radiology, Laikon General Hospital

‡Department of Radiology and Nuclear Medicine, Evangelismos General Hospital, Athens, Greece.

Received for publication July 25, 2023; revision accepted November 15, 2023.

Conflicts of interest and sources of funding: TPV has participated in advisory boards and received honoraria from Merck.

Correspondence to: Theodoros P. Vassilakopoulos, MD, PhD, Department of Hematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens 11527, Greece. E-mail: [email protected]; [email protected].

Comments (0)

No login
gif